Ara DMAP

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameAra DMAP
Drug Alias Name6-dimethylaminopurine arabinosideNSC-407371CRU-550
ClassificationSmall molecules > Nucleosides and nucleotide derivtivesSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVaricella Zoster Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsVaricella Zoster Virus Infection

Other Information

ATC CodeN/A
Related LinksN/A